Patient Navigation for Blood Cancer

Phase-Based Progress Estimates
John B Amos Cancer Center, Columbus, GABlood Cancer+2 MorePatient Navigation - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial is testing a financial navigation program to help cancer patients and their spouses understand and manage the financial aspects of cancer care. The goal is to reduce financial worries and improve quality of life.

Eligible Conditions
  • Metastatic Cancer
  • Recurrent Malignant Solid Tumor
  • Blood Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: Up to 12 months

Up to 12 months
Community/clinic assistance
Emergency department/hospital use
Financial worry
Household financial hardship
Qualitative assessment of the intervention
Quality of life: patient
Quality of life: spouse
Spouse caregiver burden
Treatment adherence

Trial Safety

Trial Design

2 Treatment Groups

Group I (usual care)
1 of 2
Group II (financial navigation intervention)
1 of 2

Active Control

Experimental Treatment

1072 Total Participants · 2 Treatment Groups

Primary Treatment: Patient Navigation · No Placebo Group · N/A

Group II (financial navigation intervention)Experimental Group · 4 Interventions: Educational Intervention, Quality-of-Life Assessment, Questionnaire Administration, Patient Navigation · Intervention Types: Other, Other, Other, Behavioral
Group I (usual care)ActiveComparator Group · 3 Interventions: Educational Intervention, Quality-of-Life Assessment, Questionnaire Administration · Intervention Types: Other, Other, Other
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
Completed Phase 2

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 12 months

Who is running the clinical trial?

Southwest Oncology GroupLead Sponsor
387 Previous Clinical Trials
261,881 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,156 Previous Clinical Trials
41,162,534 Total Patients Enrolled
Veena ShankaranPrincipal InvestigatorSouthwest Oncology Group
3 Previous Clinical Trials
440 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 21 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You can participate in the trial if you had cancer in the past but it has been treated and you have been cancer-free for at least 2 years. If you had certain types of cancer that were not invasive, such as skin or cervical cancer, you are also eligible.
You can participate in the trial if you have a solid tumor that has spread to other parts of the body for the first time and it has been at least 6 months since you were diagnosed with an earlier stage of cancer.

Frequently Asked Questions

Are there any vacancies for individuals interested in participating in this trial?

"Indeed, the information on specifies that recruitment for this medical trial is actively underway. The study was first published on July 15th 2021 and recently modified on March 29th 2022." - Anonymous Online Contributor

Unverified Answer

In what capacity are medical facilities participating in this research?

"This medical research is recruiting patients from the Delaware Health Center-Grady Cancer Centre in Ohio, HaysMed University of Kansas Health System in Kansa and Kaiser Permanente-South San Francisco in Illinois. Furthermore, there are another 100 sites enrolling people for this experiment." - Anonymous Online Contributor

Unverified Answer

What is the participant capacity for this clinical research?

"This trial necessitates the inclusion of 1072 volunteers that meet the prerequisites. Delaware Health Center-Grady Cancer Center in Delaware, Ohio and HaysMed University of Kansas Health System in Hays are two locations where participants may enroll." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.